Investigation | Result | Reference range |
---|---|---|
White blood cell count, × 109/L | 13.41 | 4.31–11.00 |
Absolute neutrophil count, × 109/L | 8.70 | 1.63–7.55 |
Absolute lymphocyte count, × 109/L | 0.36 | > 3 |
Hemoglobin, g/dL | 101 | 107–134 |
Platelets, × 109/L | 30 | 206–369 |
C-reactive protein, mg/L | 268.9 | 0.1–1.0 |
ESR, mm/h | 9 | 2–34 |
Ferritin, ng/mL | 1061.5 | 13.7–78.8 |
Sodium, mmol/L | 132 | 135–143 |
Albumin, g/dL | 22 | 37–50 |
Alanine transaminase, U/L | 81 | < 24 |
Aspartate transaminase, U/L | 84 | < 43 |
Creatinine, μmol/L | 182 | 25–50 |
d-Dimer, μg/mL | 3.35 | < 0.50 |
Fibrinogen, g/L | 6.6 | 1.9–4.3 |
International normalized ratio | 1.4 | 0.8–1.2 |
Triglycerides, mmol/L | 3.35 | < 1.02 |
Troponin I, ng/L | 199.7 | < 30.9 |
NT-proBNP, pmol/L | 2960 | < 150 |
Nasopharyngeal SARS-CoV-2 PCR | Negative | NA |
Anti-SARS-CoV-2 IgG | Positive | NA |
ECG | Sinus tachycardia RV conduction delay | NA |
Echocardiography | Normal coronary arteries, moderately reduced RV function, echo bright areas on LV myocardium and papillary muscles, small pericardial effusion | NA |
Note: ECG = electrocardiogram, ESR = erythrocyte sedimentation rate, IgG = immunoglobulin G, LV = left ventricle, NA = not applicable, NT-proBNP = N-terminal-pro-brain-type natriuretic peptide, PCR = polymerase chain reaction, RV = right ventricle, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.